In silico transcriptome screens identify epidermal growth factor receptor inhibitors as therapeutics for noise-induced hearing loss

Abstract excerpt

Noise-induced hearing loss (NIHL) is a common sensorineural hearing impairment that lacks U.S. Food and Drug Administration-approved drugs. To fill the gap in effective screening models, we used an in silico transcriptome-based drug screening approach, identifying 22 biological pathways and 64 potential small molecule treatments for NIHL. Two of these, afatinib and zorifertinib [epidermal growth factor receptor...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Ear and Head Tumors
• Share to Hearing, Cochlea, Tinnitus, Genetics
• Share to NF-κB Signaling Pathways